1-Cyclopropyl-N-((5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)methyl)methanamine

Catalog No. :
ACDNRH183
CAS No. :
919347-13-0
Molecular Formula :
C16H25BN2O2
Molecular Weight :
288.20

IUPAC Name:1-cyclopropyl-N-((5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)methyl)methanamine

1-Cyclopropyl-N-((5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)methyl)methanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$823.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Cyclopropyl-N-((5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)methyl)methanamine
IUPAC Name1-cyclopropyl-N-((5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)methyl)methanamine
Molecular FormulaC16H25BN2O2
Molecular Weight288.20
SMILESCC1(C)C(C)(C)OB(C2=CN=CC(CNCC3CC3)=C2)O1
InChI KeyNXDFLMFGYVIOPM-UHFFFAOYSA-N
Synonym3-PYRIDINEMETHANAMINE, N-(CYCLOPROPYLMETHYL)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-;N-(cyclopropylmethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-Pyridinemethanamine;1-Cyclopropyl-N-((5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)methyl)methanami
CAS No.919347-13-0

Synthetic Route by SureRoute

1. ACDNRH183 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXZSA965 route compound structure diagram
    ACXZSA965848093-29-8 In Stock
  2. Plus
  3. ACKYTW152 route compound structure diagram
    ACKYTW1522516-47-4 In Stock
  4. Then
  5. ACDNRH183 route product structure diagram
    ACDNRH183919347-13-0
Inquiry

2. ACDNRH183 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDNRH183 route product structure diagram
    ACDNRH183919347-13-0
Inquiry

Comments (0)